Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGNYZ) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ligand Pharmaceuticals (LGNYZ) over the last 15 years, with Q3 2025 value amounting to 0.21.

  • Ligand Pharmaceuticals' Asset Utilization Ratio rose 2377.26% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year increase of 2377.26%. This contributed to the annual value of 0.19 for FY2024, which is 1409.27% up from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.21 for Q3 2025, which was up 2377.26% from 0.2 recorded in Q2 2025.
  • Ligand Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.26 during Q1 2023, with a 5-year trough of 0.14 in Q1 2024.
  • For the 5-year period, Ligand Pharmaceuticals' Asset Utilization Ratio averaged around 0.19, with its median value being 0.19 (2022).
  • As far as peak fluctuations go, Ligand Pharmaceuticals' Asset Utilization Ratio skyrocketed by 8335.17% in 2021, and later plummeted by 4626.81% in 2024.
  • Quarter analysis of 5 years shows Ligand Pharmaceuticals' Asset Utilization Ratio stood at 0.19 in 2021, then grew by 15.21% to 0.22 in 2022, then fell by 22.05% to 0.17 in 2023, then rose by 4.45% to 0.18 in 2024, then grew by 17.55% to 0.21 in 2025.
  • Its last three reported values are 0.21 in Q3 2025, 0.2 for Q2 2025, and 0.2 during Q1 2025.